BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 28513646)

  • 21. Bacterial exopolysaccharide based magnetic nanoparticles: a versatile nanotool for cancer cell imaging, targeted drug delivery and synergistic effect of drug and hyperthermia mediated cancer therapy.
    Sivakumar B; Aswathy RG; Sreejith R; Nagaoka Y; Iwai S; Suzuki M; Fukuda T; Hasumura T; Yoshida Y; Maekawa T; Sakthikumar DN
    J Biomed Nanotechnol; 2014 Jun; 10(6):885-99. PubMed ID: 24749386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound-induced mild hyperthermia improves the anticancer efficacy of both Taxol® and paclitaxel-loaded nanocapsules.
    Boissenot T; Bordat A; Larrat B; Varna M; Chacun H; Paci A; Poinsignon V; Fattal E; Tsapis N
    J Control Release; 2017 Oct; 264():219-227. PubMed ID: 28867377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fe
    Lu Q; Dai X; Zhang P; Tan X; Zhong Y; Yao C; Song M; Song G; Zhang Z; Peng G; Guo Z; Ge Y; Zhang K; Li Y
    Int J Nanomedicine; 2018; 13():2491-2505. PubMed ID: 29719396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and Paclitaxel for the combination of Chemo/Magnetocaloric therapy on MDA-MB-231 cells.
    Cai D; Liu L; Han C; Ma X; Qian J; Zhou J; Zhu W
    Sci Rep; 2019 Oct; 9(1):14475. PubMed ID: 31597929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma.
    Ito A; Fujioka M; Yoshida T; Wakamatsu K; Ito S; Yamashita T; Jimbow K; Honda H
    Cancer Sci; 2007 Mar; 98(3):424-30. PubMed ID: 17270032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shape-controlled fabrication of magnetite silver hybrid nanoparticles with high performance magnetic hyperthermia.
    Ding Q; Liu D; Guo D; Yang F; Pang X; Che R; Zhou N; Xie J; Sun J; Huang Z; Gu N
    Biomaterials; 2017 Apr; 124():35-46. PubMed ID: 28187393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous magnetic nanoparticle cancer hyperthermia.
    Huang HS; Hainfeld JF
    Int J Nanomedicine; 2013; 8():2521-32. PubMed ID: 23901270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biocompatible Nanoclusters with High Heating Efficiency for Systemically Delivered Magnetic Hyperthermia.
    Albarqi HA; Wong LH; Schumann C; Sabei FY; Korzun T; Li X; Hansen MN; Dhagat P; Moses AS; Taratula O; Taratula O
    ACS Nano; 2019 Jun; 13(6):6383-6395. PubMed ID: 31082199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of Magnetic Liposomes in Cancer Therapies.
    T S A; Shalumon KT; Chen JP
    Curr Pharm Des; 2019; 25(13):1490-1504. PubMed ID: 31109270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment.
    Petryk AA; Giustini AJ; Gottesman RE; Kaufman PA; Hoopes PJ
    Int J Hyperthermia; 2013 Dec; 29(8):845-51. PubMed ID: 24144336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biocompatibility of Fe₃O₄@Au composite magnetic nanoparticles in vitro and in vivo.
    Li Y; Liu J; Zhong Y; Zhang J; Wang Z; Wang L; An Y; Lin M; Gao Z; Zhang D
    Int J Nanomedicine; 2011; 6():2805-19. PubMed ID: 22131827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal cancer treatment: real time monitoring, optimization, and synergistic effects.
    Myhr G
    Technol Cancer Res Treat; 2008 Oct; 7(5):409-14. PubMed ID: 18783293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic nanoparticle hyperthermia enhances radiation therapy: A study in mouse models of human prostate cancer.
    Attaluri A; Kandala SK; Wabler M; Zhou H; Cornejo C; Armour M; Hedayati M; Zhang Y; DeWeese TL; Herman C; Ivkov R
    Int J Hyperthermia; 2015 Jun; 31(4):359-74. PubMed ID: 25811736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of chemohyperthermia with docetaxel-embedded magnetoliposomes as minimally invasive local treatment for cancer.
    Yoshida M; Watanabe Y; Sato M; Maehara T; Aono H; Naohara T; Hirazawa H; Horiuchi A; Yukumi S; Sato K; Nakagawa H; Yamamoto Y; Sugishita H; Kawachi K
    Int J Cancer; 2010 Apr; 126(8):1955-1965. PubMed ID: 19711342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultra magnetic liposomes for MR imaging, targeting, and hyperthermia.
    Béalle G; Di Corato R; Kolosnjaj-Tabi J; Dupuis V; Clément O; Gazeau F; Wilhelm C; Ménager C
    Langmuir; 2012 Aug; 28(32):11834-42. PubMed ID: 22799267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of infusion strategy for achieving repeatable nanoparticle distribution and quantification of thermal dosage using micro-CT Hounsfield unit in magnetic nanoparticle hyperthermia.
    LeBrun A; Joglekar T; Bieberich C; Ma R; Zhu L
    Int J Hyperthermia; 2016; 32(2):132-43. PubMed ID: 26758242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.
    Sadhukha T; Wiedmann TS; Panyam J
    Biomaterials; 2013 Jul; 34(21):5163-71. PubMed ID: 23591395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer hyperthermia using magnetic nanoparticles.
    Kobayashi T
    Biotechnol J; 2011 Nov; 6(11):1342-7. PubMed ID: 22069094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 90Y-CA/SPIONs for dual magnetic hyperthermia-radionuclide nanobrachytherapy of solid tumours.
    Vukadinović A; Milanović Z; Ognjanović M; Janković D; Radović M; Mirković M; Karageorgou MA; Bouziotis P; Erić S; Vranješ-Đurić S; Antić B; Prijović Ž
    Nanotechnology; 2022 Jul; 33(40):. PubMed ID: 35728572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model.
    Jeon MJ; Ahn CH; Kim H; Chung IJ; Jung S; Kim YH; Youn H; Chung JW; Kim YI
    J Exp Clin Cancer Res; 2014 Jul; 33(1):57. PubMed ID: 25037747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.